298 related articles for article (PubMed ID: 32058931)
1. TLR2 deficiency attenuated chronic intermittent hypoxia-induced neurocognitive deficits.
Li W; Yu Y; Li D; Xu N; Fang J; Sun Y; Xu M; Wang X; Han X; Zhang X; Lv C; Han F
Int Immunopharmacol; 2020 Apr; 81():106284. PubMed ID: 32058931
[TBL] [Abstract][Full Text] [Related]
2. Abnormal lipid droplets accumulation induced cognitive deficits in obstructive sleep apnea syndrome mice via JNK/SREBP/ACC pathway but not through PDP1/PDC pathway.
Li D; Xu N; Hou Y; Ren W; Zhang N; Wang X; Sun Y; Lu W; Qu G; Yu Y; Lv C; Han F
Mol Med; 2022 Jan; 28(1):3. PubMed ID: 35030992
[TBL] [Abstract][Full Text] [Related]
3. P2X7 Receptor Antagonism Attenuates the Intermittent Hypoxia-induced Spatial Deficits in a Murine Model of Sleep Apnea Via Inhibiting Neuroinflammation and Oxidative Stress.
Deng Y; Guo XL; Yuan X; Shang J; Zhu D; Liu HG
Chin Med J (Engl); 2015 Aug; 128(16):2168-75. PubMed ID: 26265609
[TBL] [Abstract][Full Text] [Related]
4. TLR2 antagonism attenuates the hippocampal neuronal damage in a murine model of sleep apnea via inhibiting neuroinflammation and oxidative stress.
Deng Y; Liu K; Pan Y; Ren J; Shang J; Chen L; Liu H
Sleep Breath; 2020 Dec; 24(4):1613-1621. PubMed ID: 32170671
[TBL] [Abstract][Full Text] [Related]
5. Sevoflurane exaggerates cognitive decline in a rat model of chronic intermittent hypoxia by aggravating microglia-mediated neuroinflammation via downregulation of PPAR-γ in the hippocampus.
Dong P; Zhao J; Li N; Lu L; Li L; Zhang X; Yang B; Zhang L; Li D
Behav Brain Res; 2018 Jul; 347():325-331. PubMed ID: 29574103
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor-4 deficiency alleviates chronic intermittent hypoxia-induced renal injury, inflammation, and fibrosis.
Zhang Y; Su X; Zou F; Xu T; Pan P; Hu C
Sleep Breath; 2019 Jun; 23(2):503-513. PubMed ID: 30099700
[TBL] [Abstract][Full Text] [Related]
7. Sesamol alleviates chronic intermittent hypoxia-induced cognitive deficits via inhibiting oxidative stress and inflammation in rats.
Zhang P; Wang Y; Wang H; Cao J
Neuroreport; 2021 Jan; 32(2):105-111. PubMed ID: 33323839
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of atorvastatin on hippocampal neuronal damage caused by chronic intermittent hypoxia: Involving TLR4 and its downstream signaling pathway.
Deng Y; Yuan X; Guo XL; Zhu D; Pan YY; Liu HG
Respir Physiol Neurobiol; 2015 Nov; 218():57-63. PubMed ID: 26200444
[TBL] [Abstract][Full Text] [Related]
9. Role of the Nrdp1 in Brain Injury Induced by Chronic Intermittent Hypoxia in Rats via Regulating the Protein Levels of ErbB3.
Zhu J; Zhu Z; Ren Y; Dong Y; Li Y; Yang X
Neurotox Res; 2020 Jun; 38(1):124-132. PubMed ID: 32200526
[TBL] [Abstract][Full Text] [Related]
10. Altered Wnt Signaling Pathway in Cognitive Impairment Caused by Chronic Intermittent Hypoxia: Focus on Glycogen Synthase Kinase-3β and β-catenin.
Pan YY; Deng Y; Xie S; Wang ZH; Wang Y; Ren J; Liu HG
Chin Med J (Engl); 2016 Apr; 129(7):838-45. PubMed ID: 26996481
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective mechanism of Lycium barbarum polysaccharides against hippocampal-dependent spatial memory deficits in a rat model of obstructive sleep apnea.
Lam CS; Tipoe GL; So KF; Fung ML
PLoS One; 2015; 10(2):e0117990. PubMed ID: 25714473
[TBL] [Abstract][Full Text] [Related]
12. AMPK activation increases postoperative cognitive impairment in intermittent hypoxia rats via direct activating PAK2.
Mei X; Tan G; Qing W
Behav Brain Res; 2020 Feb; 379():112344. PubMed ID: 31706798
[TBL] [Abstract][Full Text] [Related]
13. The protective role of Nrf2 on cognitive impairment in chronic intermittent hypoxia and sleep fragmentation mice.
Qiu X; Li L; Wei J; An X; Ampadu JA; Zheng W; Yu C; Peng C; Li X; Cai X
Int Immunopharmacol; 2023 Mar; 116():109813. PubMed ID: 37254290
[TBL] [Abstract][Full Text] [Related]
14. Chronic intermittent hypoxia induces liver fibrosis in mice with diet-induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways.
Kang HH; Kim IK; Lee HI; Joo H; Lim JU; Lee J; Lee SH; Moon HS
Biochem Biophys Res Commun; 2017 Aug; 490(2):349-355. PubMed ID: 28623125
[TBL] [Abstract][Full Text] [Related]
15. SENP1 modulates chronic intermittent hypoxia-induced inflammation of microglia and neuronal injury by inhibiting TOM1 pathway.
Wang H; Wang X; Shen Y; Wang Y; Yang T; Sun J; Liu S
Int Immunopharmacol; 2023 Jun; 119():110230. PubMed ID: 37137262
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Calcium-Sensing Receptor Alleviates Chronic Intermittent Hypoxia-Induced Cognitive Dysfunction via CaSR-PKC-ERK1/2 Pathway.
Ying H; Zhang Z; Wang W; Yang Z; You C; Li Y; Cai X; Li X
Mol Neurobiol; 2023 Apr; 60(4):2099-2115. PubMed ID: 36600080
[TBL] [Abstract][Full Text] [Related]
17. SENP1 regulates intermittent hypoxia-induced microglia mediated inflammation and cognitive dysfunction via wnt/β-catenin pathway.
Ou X; Wang H; Shen Y; Zhang W; Sun J; Liu S
Eur J Pharmacol; 2024 Jul; 975():176659. PubMed ID: 38762158
[TBL] [Abstract][Full Text] [Related]
18. Manganese superoxide dismutase protects mouse cortical neurons from chronic intermittent hypoxia-mediated oxidative damage.
Shan X; Chi L; Ke Y; Luo C; Qian S; Gozal D; Liu R
Neurobiol Dis; 2007 Nov; 28(2):206-15. PubMed ID: 17719231
[TBL] [Abstract][Full Text] [Related]
19. Chronic intermittent hypoxia exposure-induced atherosclerosis: a brief review.
Song D; Fang G; Greenberg H; Liu SF
Immunol Res; 2015 Dec; 63(1-3):121-30. PubMed ID: 26407987
[TBL] [Abstract][Full Text] [Related]
20. Pseudoginsenoside GQ mitigates chronic intermittent hypoxia-induced cognitive damage by modulating microglia polarization.
Tian Y; Wang S; Tong W; Wang H; Zhang Y; Teng B
Int Immunopharmacol; 2024 Jan; 126():111234. PubMed ID: 37977071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
